Mounjaro®
Starting from £179.99/mo
Start journey Learn moreZofran (ondansetron) is sometimes suggested as a remedy for Mounjaro nausea, but the picture is more complicated than a quick Google search suggests. Mounjaro is a prescription-only weight-management medicine — any decision about adding another prescription drug alongside it belongs with a clinician, not a forum thread. Here is what the evidence actually says, and when to ask for help.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Ondansetron is a serotonin 5-HT3 receptor antagonist, originally developed for chemotherapy-induced nausea. It is effective in several clinical contexts, but its use alongside tirzepatide has not been studied in controlled trials, and UK prescribers do not routinely co-prescribe it for Mounjaro-related nausea. In the UK, ondansetron is a prescription-only medicine, the branded version called Zofran is not the name used here, though the drug itself (ondansetron) is available under that generic name.
The nausea most people experience on Mounjaro is caused by the medicine slowing gastric emptying and signalling the gut-brain axis, a direct pharmacological effect, not a sign that something has gone wrong. The NHS patient information for tirzepatide notes that nausea is a common side effect and sets out practical steps before any medication is considered. Adding a second prescription drug without clinical oversight introduces its own risks: ondansetron can prolong the QT interval on an ECG, interact with other medicines, and mask symptoms that might otherwise prompt someone to call their GP. If you are struggling with nausea on Mounjaro, the right first step is talking to your prescriber, not sourcing a separate anti-nausea drug independently.
Our prescribers at nume discuss side-effect management as a core part of every consultation, not as an afterthought.
Most Mounjaro nausea responds well to behavioural adjustments. Eating smaller portions, avoiding high-fat or very rich meals, and staying upright for a while after eating all help. Keeping well hydrated (small sips rather than large glasses) prevents the dehydration that can compound GI symptoms. Ginger-based products (ginger tea, ginger biscuits) have modest evidence behind them for mild nausea and carry no interaction risk. The NHS recommends these approaches before reaching for any anti-nausea medicine.
If nausea is making eating very difficult, a prescriber may occasionally consider an over-the-counter antiemetic such as cyclizine or metoclopramide on a short-term basis, but this remains a clinical decision, not a self-medication call. The detail on why Mounjaro causes nausea and what to expect at each stage of treatment helps set realistic expectations. Symptoms are typically worst in the first fortnight after a dose change and ease considerably after that. Understanding that pattern prevents people from stopping treatment prematurely, or from reaching for medicines they do not need. If you want to know what to take for Mounjaro nausea, our dedicated page walks through the options that are appropriate at each stage, from simple dietary measures through to when a clinical conversation is warranted. There is also useful practical guidance in our page on reducing nausea on Mounjaro, which covers meal timing, food choices and when to contact your clinical team.
For most people, patience and a few simple changes get them through. A prescription anti-nausea drug like ondansetron is a much further step along that path.
Nausea that settles within a week or two of starting a new dose is normal and expected. The full picture of how long nausea typically lasts on Mounjaro is worth reading if you are in that window, for many people it is transient, and the discomfort does not reflect long-term tolerance. If nausea is still significantly affecting daily life after two to three weeks at the same dose, or if you are losing weight rapidly through vomiting, contact your prescriber. They may consider slowing your titration schedule, which is the most effective and clinically appropriate lever available.
Persistent nausea that is worsening rather than settling is a different matter. The MHRA's January 2026 Drug Safety Update for GLP-1 medicines flagged acute pancreatitis as an infrequent but serious risk, the key symptom being severe, constant abdominal pain that radiates to the back, often with vomiting that does not ease. This is not the ordinary nausea of dose adjustment. If you experience it, stop the injection and go to A&E or call 999. Do not wait for it to pass on its own, and do not take an anti-nausea tablet and carry on.
The broader profile of Mounjaro's side effects covers the full range of what to watch for, nausea sits alongside constipation, diarrhoea, indigestion and fatigue as the most commonly reported effects.
Most nausea on tirzepatide is unpleasant but not dangerous. A few patterns require prompt action. Severe stomach pain reaching into the back (especially if it is constant and does not shift with position) needs same-day assessment for pancreatitis. Signs of significant dehydration from repeated vomiting (dark urine, dizziness on standing, very low urine output) also need medical review, because dehydration can put strain on the kidneys. An allergic reaction (swelling of the face or throat, hives, difficulty breathing) is an emergency: call 999.
If you notice any of those warning signs, the answer is not Zofran or any other anti-nausea tablet. It is the GP, an urgent care centre, or 999 depending on severity. You can also report any suspected reaction to the MHRA's Yellow Card scheme, which collects real-world safety data on all medicines including tirzepatide.
If you are concerned about how your body is responding to treatment and you are a patient with a nume consultation, our aftercare team is available seven days a week. Mounjaro is a clinically supervised medicine, that supervision is there to be used. You can also read about nausea and other experiences people have at different stages of treatment on our nausea from Mounjaro overview.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.